Dulera Aerosol
NDC Package 78206-126-02

11-digit billing NDC: 78206012602 · Billing unit: GM

Package Information

Dulera (mometasone furoate and formoterol fumarate dihydrate) aerosols is dULERA is indicated for the twice-daily treatment of asthma in patients 5 years of age and older. This formulation utilizes a aerosol delivery system. Marketed by Organon Llc, this product is identified by NDC 78206-126 and is authorized under FDA application NDA022518.

Identification & Billing

NDC Package Code
78206-126-02
Package Description
1 CANISTER in 1 CARTON / 60 AEROSOL in 1 CANISTER
Product Code
11-Digit Billing Format
78206012602
Billing Unit
GM - Billing unit of "gram" is used when a product is measured by its weight.
RxNorm Crosswalk
  • RxCUI: 1246308 - mometasone furoate/formoterol fumarate 100/5 MCG/INHAL Metered Dose Inhaler, 120 Actuations
  • RxCUI: 1246308 - 120 ACTUAT formoterol fumarate 0.005 MG/ACTUAT / mometasone furoate 0.1 MG/ACTUAT Metered Dose Inhaler
  • RxCUI: 1246308 - formoterol fumarate 0.005 MG / mometasone furoate 0.1 MG per ACTUAT Metered Dose Inhaler, 120 ACTUAT
  • RxCUI: 1246308 - formoterol fumarate 5 MCG / mometasone furoate 100 MCG per ACTUAT Metered Dose Inhaler, 120 ACTUAT
  • RxCUI: 1246310 - Dulera 100/5 MCG/INHAL Metered Dose Inhaler, 120 Actuations

Clinical Specifications

Proprietary Name
Dulera
Non-Proprietary Name
Mometasone Furoate And Formoterol Fumarate Dihydrate
Substance Name
Mometasone Furoate; Formoterol Fumarate
Dosage Form
Aerosol - A product that is packaged under pressure and contains therapeutically active ingredients that are released upon activation of an appropriate valve system; it is intended for topical application to the skin as well as local application into the nose (nasal aerosols), mouth (lingual aerosols), or lungs (inhalation aerosols).
Administration Route
Respiratory (inhalation) - Administration within the respiratory tract by inhaling orally or nasally for local or systemic effect.
Usage Information
DULERA is indicated for the twice-daily treatment of asthma in patients 5 years of age and older. DULERA should be used for patients not adequately controlled on a long-term asthma-control medication such as an inhaled corticosteroid (ICS) or whose disease warrants initiation of treatment with both an ICS and long-acting beta2-adrenergic agonist (LABA).

Regulatory & Marketing

Labeler Name
Organon Llc
Product Type
Human Prescription Drug
FDA Application #
NDA022518
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
06-01-2021
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (78206-126). Click a package code to view its specific billing and regulatory data.

1 CANISTER in 1 CARTON / 120 AEROSOL in 1 CANISTER
1 CANISTER in 1 CARTON / 60 AEROSOL in 1 CANISTER

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 78206-126-02 identifies a specific commercial package of 1 canister in 1 carton / 60 aerosol in 1 canister of Dulera, a human prescription drug labeled by Organon Llc. This aerosol is formulated for respiratory (inhalation) use and contains mometasone furoate; formoterol fumarate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Organon Llc on June 01, 2021. The current certification is valid through December 31, 2027.

How is this Organon Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 78206012602. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
78206-126-02
11-Digit CMS (5-4-2)
78206-0126-02

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.